State-of-the-Art Biomarker Testing in Gastrointestinal Cancer: Guidance for Oncologists and Pathologists to Improve Patient Outcomes

Improve your ability to manage gastrointestinal cancers with this in-depth multidisciplinary discussion of advances in biomarker testing and use of targeted therapy including an on-demand webcast downloadable slideset and expert commentaries.

Share

Program Content

Activities

GI Biomarkers
State-of-the-Art Biomarker Testing in Gastrointestinal Cancer: Guidance for Oncologists and Pathologists
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2022

Expires: February 22, 2023

Activities

GI Biomarkers
State-of-the-Art Biomarker Testing in Gastrointestinal Cancer: Guidance for Oncologists and Pathologists
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: April 18, 2022

Expires: April 17, 2023

Activities

GI Cancer Biomarkers
What I Want My Colleagues to Know About State-of-the-Art Biomarker Testing for GI Malignancies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2022

Expires: April 26, 2023

Faculty

cover img faculity

E. Scott Kopetz, MD, PhD, FACP

Assistant Professor
Department of Gastrointestinal Medical Oncology
The University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Christopher H. Lieu, MD

Associate Professor
Associate Director for Clinical Research
Division of Medical Oncology
University of Colorado Cancer Center
Co-Director, GI Medical Oncology
Division of Medical Oncology
University of Colorado Hospital
Aurora, Colorado

cover img faculity

Dipen Maru, MD

Professor
Department of Pathology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Pfizer, Inc.

Seagen Inc.

Partners

American Society for Clinical Pathology

ProCE Banner